Hagan Joseph P

Average Profitability
<0.0001%
Insider Buys Quantity
4
Insider Buys Sum
$329,269.32
Insider Sells Quantity
16
Insider Sells Sum
$1.92M

Insider Activity of Hagan Joseph P

According to the SEC Form 4 filings, Hagan Joseph P, being in a position of

  1. Chief Executive Officer at Regulus Therapeutics Inc.,
    оver the last 12 months, has bought 0 shares, and sold 14580 shares for $17,359,
    over all time since 2016-03-03, has bought 362974 shares for $329,269, and sold 120277 shares for $121,783.

The largest purchase of all time was on 2017-07-25 and amounted to 219780 shares of Regulus Therapeutics Inc. for $200,000.

The largest sale of all time was on 2022-01-03 and amounted to 79366 shares of Aurinia Pharmaceuticals Inc. for $1.79M.

Biography of Hagan Joseph P

No biography is available at this moment.

2024-01-18SaleRegulus Therapeutics Inc.
RGLS
Chief Executive Officer
14,580
0.0687%
$1.19$17,359+33.2%
2023-05-19SaleAurinia Pharmaceuticals Inc.
AUPH
director
272
0.0002%
$10.58$2,878-22.65%
2022-01-26PurchaseRegulus Therapeutics Inc.
RGLS
President and CEO
100,000
0.0685%
$0.22$21,520-15.91%
2022-01-03SaleAurinia Pharmaceuticals Inc.
AUPH
director
79,366
0.0563%
$22.59$1.79M-54.58%
2021-05-17SaleRegulus Therapeutics Inc.
RGLS
President and CEO
4,186
0.0053%
$0.89$3,726-53.85%
2021-02-16SaleRegulus Therapeutics Inc.
RGLS
President and CEO
4,144
0.0052%
$1.72$7,128-62.37%
2020-11-16SaleRegulus Therapeutics Inc.
RGLS
President and CEO
6,094
0.0122%
$0.52$3,176+68.18%
2020-08-14SaleRegulus Therapeutics Inc.
RGLS
President and CEO
4,245
0.011%
$0.60$2,568+52.46%
2020-05-15SaleRegulus Therapeutics Inc.
RGLS
President and CEO
4,426
0.0155%
$0.63$2,774+40%
2020-02-18SaleRegulus Therapeutics Inc.
RGLS
President and CEO
4,324
0.018%
$0.83$3,591-19.28%
2020-01-02SaleRegulus Therapeutics Inc.
RGLS
President and CEO
8,345
0.0332%
$0.97$8,067-33.66%
2019-11-14SaleRegulus Therapeutics Inc.
RGLS
President and CEO
5,838
0.0279%
$0.64$3,736+4.69%
2019-10-01SaleRegulus Therapeutics Inc.
RGLS
President and CEO
8,743
0.0425%
$0.68$5,969+2.99%
2019-08-15SaleRegulus Therapeutics Inc.
RGLS
President and CEO
4,375
0.0203%
$0.55$2,409+24.56%
2019-07-01SaleRegulus Therapeutics Inc.
RGLS
President and CEO
5,783
0.0264%
$1.31$7,584-49.28%
2019-05-16SaleRegulus Therapeutics Inc.
RGLS
President and CEO
39,352
0.2413%
$1.22$47,966-40.34%
2019-05-07PurchaseRegulus Therapeutics Inc.
RGLS
President and CEO
33,194
0.1788%
$1.08$35,850-40%
2019-04-01SaleRegulus Therapeutics Inc.
RGLS
President and CEO
5,842
0.0349%
$0.98$5,731-19.39%
2017-07-25PurchaseRegulus Therapeutics Inc.
RGLS
President and CEO
219,780
0.2%
$0.91$200,000-17.12%
2016-03-03PurchaseRegulus Therapeutics Inc.
RGLS
Chief Operating Officer
10,000
0.019%
$7.19$71,900-53.41%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.